George Hubbard MD
Overview
G. Baker Hubbard III, MD
Thomas M. Aaberg Chair in Ophthalmology
Vice Chair, Clinic Operations
Director of the Retina Service
Professor of Ophthalmology
Section of Vitreoretinal Surgery & Diseases (Retina)
Section of Ocular Oncology and Pathology
G. Baker Hubbard, MD is the Thomas M. Aaberg Chair in Ophthalmology within Emory Universitys School of Medicine. He has served at Emory Eye Center since 2000 and currently holds the position of Chief of the section of Vitreoretinal Surgery & Disease. Additionally, he is Vice-chief of the Ophthalmology Service at Childrens Hospital of Atlanta, Egleston, and is past director of the Vitreoretinal Fellowship training at Emory Eye Center.
Dr. Hubbard is a graduate of Vanderbilt University School of Medicine (1988-1992), where he completed an internship (1992-1993) as well as a PGY-2 year in general surgery (1993-1994). Following that, he completed a fellowship in ophthalmic pathology at the Armed Forces Institute of Pathology in Washington, D.C. (1994-1995). In 1995 he entered a residency program at Emory Eye Center, completing it in 1998. His fellowship in vitreoretinal diseases and surgery followed at the Barnes Retina Institute, Washington University School of Medicine (1998-2000). He joined the faculty at Emory Eye Center in 2000, initially as an assistant professor, later rising to associate professor in 2006 and full professor in 2014.
Dr. Hubbard is a diplomate of the American Board of Ophthalmology. He is a fellow of the American Academy of Ophthalmology (AAO), where he is a past member of the Secretariat for State Affairs. In 2008, he received the AAOs Achievement Award. That same year, he received the Honor Award from the American Society of Retina Specialists (ASRS) and in 2011 he received the Senior Honor Award from the ASRS. He is a member of the the Macula Society, the Retina Society, the Association of Pediatric Retina Surgeons, and the American Ophthalmological Society. He is past president of the Georgia Society of Ophthalmology (GSO).
Dr. Hubbards research is focused on characterizing the clinical aspects of vitreoretinal diseases. He has special interest in pediatric vitreoretinal disorders such as retinopathy of prematurity (ROP), Coats disease, pediatric retinal detachment, and pediatric tumors of the retina such as retinoblastoma (Rb). Through his significant body of work, he has contributed to the understanding and treatment of pediatric retinal disorders through clinical trials, lectures, and numerous publications. Dr. Hubbard has served as principal investigator for clinical trials dealing with ROP, Rb, age-related macular degeneration, diabetic macular edema, and retinal vein occlusions. He currently serves as protocol co-chair for clinical trials of ROP for the DRCR/PEDIG Research Networks of the National Eye Institute.
In his teaching capacity, Dr. Hubbard has supervised over 40 vitreoretinal fellows, and the Emory ophthalmology residents have awarded him Role Model of the Year on two occasions, and Teacher of the Year once. He has authored or co-authored over 100 articles and has been an invited speaker nationally and internationally. He is a co-host of Emory Eye Centers Southeastern Vitreoretinal Seminar, an annual event, and organizes its Rb Kids Day, a day of celebration for the families of children with Rb. In 2018, he was named Ophthalmologist of the Year by the GSO. Also in 2018, he was honored with the Person of Vision Award at the annual "Night for Sight Gala," an annual fundraising event for Prevent Blindness Georgia.
Clinical Interests
Pediatric retinal disease
Retinopathy of prematurity
Retinoblastoma
Academic Appointment
- Professor of Ophthalmology, Clinical Track, Emory University School of Medicine
- Thomas M. Aaberg Sr. Chair in Ophthalmology, Emory Eye Center, Atlanta
Education
Degrees
- MD from Vanderbilt University
- BS from Vanderbilt University - Dean’s List, magna cum laude
Research
Focus
- My research is focused on characterizing the clinical aspects of vitreoretinal diseases. I have a special interest in pediatric vitreoretinal disorders such as retinopathy of prematurity, pediatric retinal detachment, and intraocular tumors in children.
Publications
-
Outcomes after unilateral bevacizumab treatment for infants with asymmetric retinopathy of prematurity.
J AAPOS Volume: 29 Page(s): 104091
04/01/2025 Authors: Nelson DG; Hubbard GB; Hutchinson AK -
NEOVASCULAR GLAUCOMA AS A PREDICTOR OF RETINOBLASTOMA HIGH-RISK HISTOPATHOLOGY IN AN INTERNATIONAL MULTICENTER STUDY.
Retina Volume: 45 Page(s): 565 - 573
03/01/2025 Authors: Negretti GS; Ushakova T; Yuri S; Vladimir P; Berry JL; Pike S; Shields CL; Hubbard GB; Eiger-Moscovich M; Pe'er J -
Longitudinal Assessment of Retinopathy of Prematurity (LONGROP) Study: Impacts of Viewing Time and Ability to Compare on Detection of Change.
Am J Ophthalmol Volume: 271 Page(s): 31 - 37
03/01/2025 Authors: Rosenblatt TR; Ghoraba HH; Ji MH; Baumal CR; Berrocal AM; Besirli CG; Drenser KA; Ells AL; Harper CA; Hubbard GB -
Retinoblastoma Outcomes Based on the 8th Edition American Joint Committee on Cancer Pathological Classification in 1411 Patients.
Ophthalmology Volume: 132 Page(s): 317 - 326
03/01/2025 Authors: Vempuluru VS; Shields CL; Berry JL; Kaliki S; High-Risk Retinoblastoma Collaborative Study Group -
CHOROIDAL OSTEOMA IN AN INFANT.
Retin Cases Brief Rep Volume: 19 Page(s): 202 - 204
03/01/2025 Authors: Eder AE; Bostwick K; Wells JR; Hubbard GB -
Vessels Spanning Avascular Retina in Familial Exudative Vitreoretinopathy.
Ophthalmol Retina
02/28/2025 Authors: Redick DW; Barnett JM; Hubbard GB -
Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma.
Am J Ophthalmol Volume: 268 Page(s): 399 - 408
12/01/2024 Authors: Arazi M; Baum A; Casavilca-Zambrano S; Alarcon-Leon S; Diaz-Coronado R; Ahmad A; Mushtaq A; Hussain M; Ushakova T; Yuri S -
HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATION: A Global Study Of 1,426 Patients From 5 Continents.
Retina Volume: 44 Page(s): 2105 - 2115
12/01/2024 Authors: Kaliki S; Vempuluru VS; Bakal KR; Dorji S; Tanna V; Shields CN; Fallon SJ; Raval V; Ahmad A; Mushtaq A -
Differentiating MYCN-amplified RB1 wild-type retinoblastoma from biallelic RB1 mutant retinoblastoma using MR-based radiomics: a retrospective multicenter case-control study.
Sci Rep Volume: 14 Page(s): 25103
10/23/2024 Authors: de Bloeme CM; Jansen RW; Cardoen L; Gricke S; van Elst S; Jessen JL; Ramasubramanian A; Skalet AH; Miller AK; Maeder P -
TOWARD AN IMAGING-CENTRIC DEFINITION OF NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY.
Retina Volume: 44 Page(s): 868 - 877
05/01/2024 Authors: Xu LT; Zheng A; Shantha JG; Yeh S; Yan J; Hubbard GB; Patel PS; Waltuck J; O'Keefe G; Jain N